CHD1L and cancer: Our data show that cancer-associated mutations at these sites involving a loss of positive charge destabilize autoinhibitory interactions between the macro domain and the ATPase motor of ALC1 and yield elevated ATPase and nucleosome remodeling activities independent of activation by PARP1/NAD+.